Literature DB >> 7204891

Interference of dopamine infusion on gamma-amino butyric acid (GABA)-stimulated prolactin increase.

G B Melis, A M Paoletti, V Mais, P Fioretti.   

Abstract

The effects of simultaneous iv administration of dopamine (DA) and gamma-amino butyric acid (GABA) were evaluated in 5 normal women. After injection of 50 mg GABA alone, PRL plasma concentrations showed a significant (p less than 0.02) rise. DA infusion (500 g/min over a 60 min period) significantly (p less than 0.02) decreased PRL plasma levels. When GABA was administered intravenously during DA infusion, the rise of PRL plasma concentrations, which was observed after injection of GABA alone, was suppressed. PRL circulating levels significantly (p less than 0.02) decreased as during infusion with DA alone. These results seem to support the hypothesis that stimulatory effects of GABA or its analogues on in vivo PRL secretion could be due to an inhibitory effect of these drugs on endogenous DA.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7204891     DOI: 10.1007/bf03349388

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  23 in total

1.  Evidence for an inhibitory gabergic control of the meso-limbic dopamine neurons: possibility of improving treatment of schizophrenia by combined treatment with neuroleptics and gabergic drugs.

Authors:  K Fuxe; T Hökfelt; A Ljungdahl; L Agnati; O Johansson; M Perez de la Mora
Journal:  Med Biol       Date:  1975-06

2.  Aminergic and peptidergic pathways in the nervous system with special reference to the hypothalamus.

Authors:  T Hökfelt; R Elde; K Fuxe; O Johansson; A Ljungdahl; M Goldstein; R Luft; S Efendic; G Nilsson; L Terenius; D Ganten; S L Jeffcoate; J Rehfeld; S Said; M Perez de la Mora; L Possani; R Tapia; L Teran; R Palacios
Journal:  Res Publ Assoc Res Nerv Ment Dis       Date:  1978

3.  Stimulating effects of gamma-hydroxybutyrate on dopamine release from the caudate nucleus and the substantia nigra of the cat.

Authors:  A Chéramy; A Nieoullon; J Glowinski
Journal:  J Pharmacol Exp Ther       Date:  1977-11       Impact factor: 4.030

4.  Dopaminergic neurons: similar biochemical and histochemical effects of gamma-hydroxybutyrate and acute lesions of the nigro-neostriatal pathway.

Authors:  J R Walters; R H Roth; G K Aghajanian
Journal:  J Pharmacol Exp Ther       Date:  1973-09       Impact factor: 4.030

5.  Stimulation of dopamine release by GABA in rat striatal slices.

Authors:  M F Giorguieff; M L Kemel; J Glowinski; M J Besson
Journal:  Brain Res       Date:  1978-01-06       Impact factor: 3.252

6.  Effects of dopamine infusion on pituitary hormone secretion in humans.

Authors:  H Leblanc; G C Lachelin; S Abu-Fadil; S S Yen
Journal:  J Clin Endocrinol Metab       Date:  1976-09       Impact factor: 5.958

7.  [3H]Spiroperidol (spiperone) binding to a putative dopamine receptor in sheep and steer pituitary and stalk median eminence.

Authors:  M J Cronin; R I Weiner
Journal:  Endocrinology       Date:  1979-02       Impact factor: 4.736

8.  The effects of intraventricular injection of gamma-aminobutyric acid (GABA) on prolactin and gonadotropin release in conscious female rats.

Authors:  E Vijayan; S M McCann
Journal:  Brain Res       Date:  1978-10-20       Impact factor: 3.252

9.  Stimulatory effects of gamma-hydroxybutyric acid on growth hormone and prolactin release in humans.

Authors:  J Takahara; S Yunoki; W Yakushiji; J Yamauchi; Y Yamane
Journal:  J Clin Endocrinol Metab       Date:  1977-05       Impact factor: 5.958

10.  Dopamine in hypophysial portal plasma of the rat during the estrous cycle and throughout pregnancy.

Authors:  N Ben-Jonathan; C Oliver; H J Weiner; R S Mical; J C Porter
Journal:  Endocrinology       Date:  1977-02       Impact factor: 4.736

View more
  3 in total

1.  Different sensitivity to sodium valproate in healthy, non-tumoral and tumoral hyperprolactinemic subjects.

Authors:  F Sarnacchiaro; A Colao; B Merola; A Di Sarno; M L Landi; C Di Somma; D Ferone; A Tolino; G Lombardi
Journal:  J Endocrinol Invest       Date:  1997-10       Impact factor: 4.256

2.  Dose-related effects of gamma-amino beta-hydroxy butyric acid (GABOB) infusion on growth hormone secretion in normal women.

Authors:  G B Melis; A M Paoletti; V Mais; N M Mastrapasqua; F Strigini; F Fruzzetti; G Guarnieri; M Gambacciani; P Fioretti
Journal:  J Endocrinol Invest       Date:  1982 Mar-Apr       Impact factor: 4.256

Review 3.  Prolactin-lowering and -releasing drugs. Mechanisms of action and therapeutic applications.

Authors:  E E Müller; V Locatelli; S Cella; A Peñalva; A Novelli; D Cocchi
Journal:  Drugs       Date:  1983-04       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.